drugset / Trial / NCT06170476
A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONV
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a multicenter, randomized, double-blind, placebo-controlled Dose-Finding study. About 200 subjects undergoing elective laparoscopic abdominal or gynecological surgery are planned to be enrolled and randomized into four groups by a ratio of 1:1:1:1.
Timeline
- Start
- 2023-11-10
- Primary completion
- 2024-02-28
- Completion
- 2024-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK21542 | Peptide | 60 ug | Intravenous |
| Subject | HSK21542 | Peptide | 120 ug | Intravenous |
| Subject | HSK21542 | Peptide | 180 ug | Intravenous |
Indications
No indication recorded.